Completed transfer of all shares of consolidated subsidiary Cohen Co., Ltd. for 200 million yen. Resignation of director announced in conjunction with the transfer.
Toyo Seikan Group Holdings has entered into an agreement on February 27, 2026, to transfer 4,662,000 shares (25.9% voting rights) of Bangkok Can Manufacturing Co., Ltd., held by its consolidated subsidiary Toyo Seikan Kaisha, Ltd., to BG Container Glass Public Company Limited for approximately JPY 3,798 million, with execution planned for April 30, 2026.
Transferred all 495,400 shares of Ashita no Team Inc. to Wellness Communications Inc. for 0.4 million yen and executed a debt waiver of 459 million yen. The transfer date is scheduled for 2026-02-27.
Sumitomo Heavy Industries, Ltd. has resolved to transfer all 17,397,200 shares of its consolidated subsidiary Shin Nippon Machinery Co., Ltd. to Torishima Pump Mfg. Co., Ltd. for 14.9 billion yen, with the transfer execution scheduled for July 1, 2026.
DOWA Holdings plans to transfer 14,980,000 shares of Fujita Kanko stock for 38.992 billion yen, recording an extraordinary profit of approximately 23 billion yen.
THK Co., Ltd. will transfer shares and loan claims of five subsidiaries in the transportation equipment business to a special purpose company, completing selection and concentration in the transportation equipment business.
On January 29, 2026, a contract was concluded to transfer all 2,000 shares of Cohen Corporation to GYET Co., Ltd. for a transfer price of 200 million yen, with the transfer scheduled for March 2, 2026.
Recruit Holdings Co., Ltd. has decided to transfer all shares of its subsidiary RGF International Recruitment Holdings Limited to Fullcast Holdings Co., Ltd. for 609 million yen.
Kyocera will transfer its chemical business to a newly established subsidiary through an absorption-type company split and transfer all shares of the subsidiary to Sumitomo Bakelite Co., Ltd. for approximately 30 billion yen. Execution planned at the end of October 2026.
Fuji Corporation has transferred all shares of its equity-method affiliate Lady Pharmacy Co., Ltd., and expects to record extraordinary income of ¥8,189 million from sale of investment securities in the consolidated financial results for the fourth quarter of fiscal 2026 ending February, as well as extraordinary income of ¥17,447 million from sale of equity-method affiliate shares in its non-consolidated financial...
Based on the announcement of changes to consolidated subsidiaries dated May 7, 2025, the company has completed the transfer of all common shares of Torii Pharmaceutical Co., Ltd. owned by the company to Torii Pharmaceutical.